02/02/2021 Cassava Sciences announces interim results from its open-label study of simufilam in mild-to-moderate AD Science watch
26/01/2021 Biohaven’s experimental AD drug fails to meet its co-primary endpoints in Phase II/III study Science watch
21/01/2021 Recent Think Brain Health conference focused on personalised plans, blood biomarkers and early conversations Science watch
20/01/2021 Trials@Home consortium invites patients and patient organisations to complete a survey on Remote Decentralised Clinical Trials Science watch
11/01/2021 Biogen launches new virtual research study with Apple, aiming to develop digital biomarkers to monitor cognitive performance and decline Science watch
11/01/2021 Eli Lilly announces positive top results from Phase II study of donanemab in Alzheimer’s disease Science watch
05/01/2021 BioXcel Therapeutics announces positive results from its TRANQUILITY study for the treatment of agitation in dementia Science watch
